{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:17:47Z","timestamp":1776363467916,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1012798713607","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T09:27:29Z","timestamp":1040635649000},"page":"89-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnosis and Management of Patients with the Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"12","author":[{"given":"Barbara Marie","family":"Alving","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,9,1]]},"reference":[{"key":"359730_CR1","first-page":"486","volume":"13","author":"GRV Hughes","year":"1986","unstructured":"Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486\u2013489.","journal-title":"J Rheumatol"},{"key":"359730_CR2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","volume":"353","author":"M Greaves","year":"1999","unstructured":"Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348\u20131353.","journal-title":"Lancet"},{"key":"359730_CR3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"W Wilson","year":"1999","unstructured":"Wilson W, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309\u20131311.","journal-title":"Arthritis Rheum"},{"key":"359730_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","volume":"ii","author":"EN Harris","year":"1983","unstructured":"Harris EN, Gharavi EA, Boey Ml, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;ii:1211\u20131214.","journal-title":"Lancet"},{"key":"359730_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1055\/s-0038-1646452","volume":"66","author":"AA Long","year":"1991","unstructured":"Long AA, Ginsberg JS, Brill\u2013Edwards P, et al. The relationship of anti\u2013phospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross\u2013sectional study. Thromb Haemost 1991;66:520\u2013524.","journal-title":"Thromb Haemost"},{"key":"359730_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","volume":"112","author":"PE Love","year":"1990","unstructured":"Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non\u2013SLE disorders. Ann Intern Med 1990;112:682\u2013698.","journal-title":"Ann Intern Med"},{"key":"359730_CR7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1212\/WNL.40.8.1181","volume":"40","author":"SR Levine","year":"1990","unstructured":"Levine SR, Deegan MJ, Futrell N, Welch KMA. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181\u20131189.","journal-title":"Neurology"},{"key":"359730_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/01.STR.23.2.189","volume":"23","author":"P Nencini","year":"1992","unstructured":"Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189\u2013193.","journal-title":"Stroke"},{"key":"359730_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/096120339600500515","volume":"5","author":"DW Branch","year":"1996","unstructured":"Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409\u2013413.","journal-title":"Lupus"},{"key":"359730_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","volume":"314","author":"R Rai","year":"1997","unstructured":"Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314:253\u2013257.","journal-title":"Br Med J"},{"key":"359730_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","volume":"166","author":"FS Cowchock","year":"1992","unstructured":"Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low\u2013dose heparin treatment.Am J Obstet Gynecol 1992; 166:1318\u20131323.","journal-title":"Am J Obstet Gynecol"},{"key":"359730_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","volume":"35","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid\u2013antibody associated recurrent pregnancy loss with lower dose aspirin and heparin.Am J Reprod Immunol 1996;35:402\u2013407.","journal-title":"Am J Reprod Immunol"},{"key":"359730_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"81","author":"B\u2013J Sanson","year":"1999","unstructured":"Sanson B\u2013J, Lensing AWA, Prins MH, et al. Safety of low\u2013molecular\u2013weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 81:668\u2013672.","journal-title":"Thromb Haemost"},{"key":"359730_CR14","doi-asserted-by":"crossref","unstructured":"Cowchock S. Treatment of antiphospholipid syndrome in pregnancy. Lupus 1998;595\u2013597.","DOI":"10.1177\/096120339800700221"},{"key":"359730_CR15","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.1378\/chest.119.1_suppl.122S","volume":"119","author":"J Ginsberg","year":"2001","unstructured":"Ginsberg J, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S\u2013131S.","journal-title":"Chest"},{"key":"359730_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1006\/jaut.2000.0410","volume":"15","author":"JH Rand","year":"2000","unstructured":"Rand JH. Antiphospholipid antibody\u2013mediated disruption of the annexin\u2013V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J Autoimmun 2000;15:107\u2013111.","journal-title":"J Autoimmun"},{"key":"359730_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1365-2141.1985.tb02988.x","volume":"59","author":"EN Harris","year":"1985","unstructured":"Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol 1985;59:227\u2013230.","journal-title":"Br J Haematol"},{"key":"359730_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2141.1985.tb02989.x","volume":"59","author":"EN Harris","year":"1985","unstructured":"Harris EN, Gharavi AE, Hegde U, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Brit J Haematol 1985;59:231\u2013234.","journal-title":"Brit J Haematol"},{"key":"359730_CR19","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V84.12.4203.bloodjournal84124203","volume":"84","author":"R Stasi","year":"1994","unstructured":"Stasi R, Stipa E, Masi M, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994;84:4203\u20134208.","journal-title":"Blood"},{"key":"359730_CR20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM199504133321504","volume":"332","author":"MA Khamashta","year":"1995","unstructured":"Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid\u2013antibody syndrome. N Engl J Med 1995;332:993\u2013997.","journal-title":"N Engl J Med"},{"key":"359730_CR21","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V86.10.3685.bloodjournal86103685","volume":"86","author":"JS Ginsberg","year":"1995","unstructured":"Ginsberg JS, Wells PS, Brill\u2013Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685\u20133691.","journal-title":"Blood"},{"key":"359730_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-127-3-199708010-00001","volume":"127","author":"S Moll","year":"1997","unstructured":"Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177\u2013185.","journal-title":"Ann Intern Med"},{"key":"359730_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0037-1615146","volume":"80","author":"A Robert","year":"1998","unstructured":"Robert A, Le Querrec A, Delahousse B, et al. Control of oral anticoagulation in patients with the antiphospholipid syndrome\u2013influence of the lupus anticoagulant on international normalized ratio. Thromb Haemost 1998;80:99\u2013103.","journal-title":"Thromb Haemost"},{"key":"359730_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/096120339600500516","volume":"5","author":"RA Asherson","year":"1996","unstructured":"Asherson RA, Piette J\u2013C. The catastrophic antiphospholipid syndrome 1996: acute multi\u2013organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus 1996;5:414\u2013417.","journal-title":"Lupus"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012798713607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012798713607\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012798713607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:11:34Z","timestamp":1754637094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012798713607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["359730"],"URL":"https:\/\/doi.org\/10.1023\/a:1012798713607","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"1 September 2001","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}